COLLEGIUM PHARMACEUTICAL, INC (COLL)

Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic. The company was founded by Michael Thomas Heffernan in April 2002 and is headquartered in Stoughton, MA.

Address

100 TECHNOLOGY CENTER DRIVE
STOUGHTON, MA 02072

Founded

2002

Number of Employees

197

Website

http://www.collegiumpharma.com

Buyback

Buyback Data 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Average
$ Amount Purchased
($ in 000s)		 - - - $68 $470 $721 $2,169 $21,631 $15,421 $48,127 $46,746 $16,919
Average Price - - - $14.20 $21.20 $13.43 $21.04 $21.13 $17.19 $23.95 $32.41 $24.36
# Shares Purchased - - - 4,819 22,191 53,700 103,074 1,023,922 897,295 2,009,147 1,442,455 694,575
Buyback Performance 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Average
Total Return to Date - - - 160.5% 74.5% 175.6% 75.9% 75.1% 115.3% 54.5% 14.2% 51.9%
S&P 500 Return to Date - - - 129.7% 104.9% 93.1% 74.8% 31.7% 37.3% 31.3% 7.4% 63.8%
Excess Total Return - - - 30.8% -30.3% 82.5% 1.0% 43.5% 78.0% 23.1% 6.8% -11.9%
Quartile Rank
Percentile Rank - - - 79% 66% 85% 66% 85% 94% 86% 69% 72%
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.

Insider Transactions

Filters

Keyboard Shortcuts: Show (a) | Close (Esc)

People also followed
BLUE ACQUISITION CORP

TELA Bio, Inc.
PACIRA PHARMACEUTICALS, INC.

TELA Bio, Inc.
Syndax Pharmaceuticals Inc
PACIRA INC

TELA Bio, Inc.